StockNews.com lowered shares of Maiden (NASDAQ:MHLD – Free Report) from a hold rating to a sell rating in a research report report published on Monday morning.
Maiden Price Performance
Shares of NASDAQ MHLD opened at $1.65 on Monday. The company has a current ratio of 0.69, a quick ratio of 0.69 and a debt-to-equity ratio of 1.02. The stock has a market capitalization of $165.34 million, a PE ratio of -6.35 and a beta of 1.27. The stock’s fifty day simple moving average is $1.95 and its two-hundred day simple moving average is $1.92. Maiden has a 12-month low of $1.19 and a 12-month high of $2.55.
Institutional Trading of Maiden
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Ieq Capital LLC bought a new stake in Maiden during the 4th quarter valued at $68,000. RPOA Advisors Inc. purchased a new stake in shares of Maiden during the 2nd quarter valued at $63,000. BNP Paribas Financial Markets lifted its holdings in shares of Maiden by 48.6% during the 1st quarter. BNP Paribas Financial Markets now owns 44,131 shares of the insurance provider’s stock valued at $99,000 after purchasing an additional 14,425 shares during the last quarter. SG Americas Securities LLC lifted its holdings in shares of Maiden by 18.3% during the 4th quarter. SG Americas Securities LLC now owns 49,405 shares of the insurance provider’s stock valued at $113,000 after purchasing an additional 7,645 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of Maiden by 11.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 66,450 shares of the insurance provider’s stock valued at $150,000 after purchasing an additional 6,645 shares during the last quarter. Institutional investors own 21.78% of the company’s stock.
About Maiden
Maiden Holdings, Ltd., through its subsidiaries, provides property and casualty insurance and reinsurance solutions to regional and specialty insurers in Europe, North America, and internationally. It operates in two segments, Diversified Reinsurance and AmTrust Reinsurance. The company writes treaties on a quota share basis and excess of loss basis.
See Also
- Five stocks we like better than Maiden
- What Investors Need to Know to Beat the Market
- Brinker International’s Price Dip is an Appetizing Entry Point
- Why Are These Companies Considered Blue Chips?
- 3 Stocks That Could Beat the September Blues
- How to Evaluate a Stock Before Buying
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Maiden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maiden and related companies with MarketBeat.com's FREE daily email newsletter.
